Effects of emissions from different type of residential heating upon cyclic guanosine monophosphate (cGMP) in blood platelets of residents

Biomarkers

Volumn 15, Issue 1, 2010, Pages 86-93

  Matthews, I P ^a   Henderson, K A ^a   Gregory, C ^a   Palmer, S R ^a   Lang, D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Blood platelets; Carbon monoxide; Cyclic guanosine monophosphate

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; CYCLIC GMP; LIQUEFIED PETROLEUM GAS; NATURAL GAS;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; HEATING; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; RESIDENTIAL AREA; SUMMER; THROMBOCYTE; WINTER;

AGED; AIR POLLUTION, INDOOR; BLOOD PLATELETS; CARBON MONOXIDE; CYCLIC GMP; FOSSIL FUELS; HEATING; HUMANS; MIDDLE AGED; PROPANE; SEASONS;

EID: 75749116687     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903311894     Document Type: Article

References (67)

1. Alm S, Mukala K, Jantunen M. (2000) Personal carbon monoxide exposures of preschool children in Helsinki, Finland: levels and determinants. Atmos Environ 34:277-285
2. Amitai Y, Zlotogorski Z, Golan-Katzav V, Wexler A, Gross D. (1998). Neuropsychological impairment from acute low-level exposure to carbon monoxide. Arch Neurol 55:845-848
3. Artinian L, Ding J, Gillette M. (2001). Carbon monoxide and nitric oxide: interacting messengers in muscarinic signalling to the brain's circadian clock. Exp Neurol 171:293-300.
4. Bian K, Doursout MF, Murad F. (2008). Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens 10:304-310
5. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AMK, Soares MP. (2000). Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1025
6. Burnett RT, Dales R, Brook J, Raizenne M, Krewski D. (1997). Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology 8:162-167
7. Castoldi A, Coccini T, Randine G, Hérnandez-Viadel M, Felipo V, Manzo L. (2006). Lymphocyte cytochrome c oxidase, cyclic GMP and cholinergic muscarinic receptors as peripheral indicators of carbon monoxide neurotoxicity after acute and repeated exposure in the rat. Life Sci 78:1915-1924
8. Cawley SM, Sawyer CL, Brunelle KF, van der Vliet A, Dostmann WR. (2007). Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells. Cell Signalling 19:1023-1033
9. Center for Disease Control. (2008). Nonfatal, unintentional, non-firerelated carbon monoxide exposures, United States, 2004-2006. MMWR Weekly 57:896-899
10. Chief Medical Officer/Chief Nursing Officer. Welsh Assembly Government. Recognising carbon monoxide poisoning -'Think CO'. CMO (2008) 9, CNO (2008) 6. Cathays Park, Cardiff: Welsh Assembly Government.
11. Coburn RF, Forster RE, Kane PB. (1965). Considerations of the physiological variables that determine the blood carboxyhaemoglobin concentrations in man. J Clin Invest 44:1899.
12. Committee on the Medical Effects of Air Pollutants. (1998). Quantification of the Effects of Air Pollution on Health in the United Kingdom. Department of Health, London: The Stationery Office.
13. Croft-Baker J, Harper A, Severs M. (2002). An investigation into the incidence of carbon monoxide poisoning in acutely ill older adults. Age Ageing 31(Suppl. 1):13.
14. Croxford B, Leonardi G, Kreis I. (2008). Self-reported neurological symptoms in relation to CO emissions due to problem gas appliance installations in London: a cross-sectional survey. Environ Health 7:34.
15. Croxford B, Hutchinson E, Leonardi G, Mckenna L, Nicholson L, Volans G, Wilkinson P. (2006). Real time carbon monoxide measurement from 270 UK homes. Proceedings of the A and WMA Indoor Environmental Quality: Problems, Research and Solutions Conference 1:400-412
16. Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, Shimojo N, Shimamoto T. (2004). Urinary cyclic GMP excretion and blood pressure levels in a general population. Atherosclerosis 172:161-166
17. Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, Shimamoto T. (2005). Relationship between urinary cGMP excretion and serum total cholesterol levels in a general population. Atherosclerosis 179:379-386
18. Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, Simamoto T. (2007). Metabolic syndrome and urinary cGMP excretion in general population. Atheroscierosis 190:423-428
19. De Bruin Y, Carrer P, Jantunen M, Hänninen O, Di Marco GS, Kephalopoulus S, Cavallo D, Maroni M. (2004). Personal carbon monoxide exposure levels: contribution of local sources to exposures and microenvironment concentrations in Milan. J Expo Anal Environ Epidemiol 14:312-322
20. Department of the Environment, Food & Rural Affairs (Defra)(2004). Nitrogen Dioxide in the United Kingdom. Air Quality Expert Group (AQEG). London: Defra.
21. Duckers H, Boehm M, True A, Yet S, San H, Park J, Clinton Webb R, Lee M, Nabel GJ, Nabel EG. (2001). Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7:693-698
22. Durante W, Schafer A. (1998). Carbon monoxide and vascular cell function. Int J Mol Med 2:255-262
23. Feelisch M. (2007). Nitrated cyclic GMP as a new cellular signal. Nat Chem Biol 3:687-688
24. Friebe A, Malkewitz J, Schultz G, Koesling D. (1996). Positive effects of pollution. Nature 382:120.
25. Gandini C, Castoldi A, Candura S, Locatelli C, Butera R, Priori S, Manzo L. (2001). Carbon monoxide cardiotoxicity. Clin Toxicol 39:35-44.
26. Harper A, Croft-Baker J. (2004). Carbon monoxide poisoning: undetected by both patients and their doctors. Age Ageing 33:105-109
27. Harrison R, Thornton C, Lawrence R, Mark D, Kinnersley Rl, Ayres J. (2002). Personal exposure monitoring of particulate matter, nitrogen dioxide and carbon monoxide, including susceptible groups. Occup Environ Med 59:671-679
28. Hartsfield C. (2002). Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 4:301-307
29. Henderson K, Parry S, Matthews I. (2006). Real-time measurement of short term peaks in environmental CO concentrations in the homes of the elderly in South Wales. J Expo Sci Environ Epidemiol 16:525-530
30. Hernández-Viadel M, Castoldi A, Coccini T, Manzo L, Erceq S, Felipo V. (2004). In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum. J Neurochem 89:1157-1165
31. Hill-Kapturczak N, Agarwal A. (2006). Carbon monoxide: from silent killer to potential remedy. Am J Physiol Renal Physiol 290:F787-8.
32. Ingi T, Cheng J, Ronnett G. (1996). Carbon monoxide: an endogenous modulator of the nitric oxide -cycle GMP Signalling System. Neuron 16:835-842
33. Institute for Environment and Health. (1998). IEH assessment on indoor air quality in the home (2): carbon monoxide. Norwich: Page Bros.
34. Jaslow D, Ufberg J, Ukasik J, Sananman P. (2001). Routine carbon monoxide screening by emergency medical technicians. Acad Emerg Med 8:288-291
35. Kao L, Nañagas M. (2005). Carbon monoxide poisoning. Med Clin North Am 89:1161-1194
36. Kao LW, Nañagas KA. (2006). Toxicity associated with carbon monoxide. Clin Lab Med 26:99-125.
37. Laquatra J, Maxwell L, Pierce M. (2005). Indoor air pollutants: limited-resource households and child care facilities. J Environ Health 67:39-43.
38. Leppert J, Ringqvist A, Ahiner J, Myrdal U, Walter-Engström M, Wennmalm A, Ringqvist I. (1997). Seasonal variations in cyclic GMP response on whole-body cooling in women with primary Raynaud's pheomenon. Clin Sci 93:175-179
39. Maines M. (1993). Carbon monoxide: an emerging regulator of cGMP in the brain. Mol Cell Neurosci 4:389-397
40. Maines M. (1997). The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554
41. Massucco P, Mattiello L, Russo I, Traversa M, Doronzo G, Anfossi G, Trovati M. (2005). High glucose rapidly activates the nitric oxide/ cyclic nucleotide pathway in human platelets via an osmotic mechanism. Throm Haemost 93:517-526
42. Morita T, Perella M, Lee M, Kourembanas S. (1995). Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92:1475-1479
43. Morita T, Mitsialis S, Koike H, Liu Y, Kourembanas S. (1997). Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272:32804-32809
44. Morris R. (2000). Low-level carbon monoxide and human health. In: Penney DG ed. Carbon Monoxide Toxicity. London: CRC Press. p. 381-391
45. Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D. (2003). Direct activation of PDE5 by cGMP: long term effects within NO/cGMP signalling. J Cell Biol 160:719-727
46. Nielsen NE, Ahlner J, Malmstedt J, Ohmas KP, Swahn E. (1999). Plasma levels of cyclic GMP and endothelia in postmenopausal women with unstable coronary artery disease. Scand J Clin Lab Invest 59:325-334
47. Otterbein L, Zuckerbraun B, Haga M, Liv F, Jong R, Usheua A, Stachular C, Bodyak N, Neal Smith R, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar R, Tzeng E, Bach FH, Choi AMK, Soares MP. (2003). Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9:183-190
48. Palmer RMJ, Ferrige AG, Moncade S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526
49. Pistono M, Bergerone S, Carrieri L, Paglia I, Stefano D, Capizzi A, Ferri M, Pescarmona G, Bosia A, Trevi G. (2002). Platelet cyclic GMP levels in unstable angina and myocardial infarction. Platelets 13:307-311
50. Powis R, Harris S, Chambers J, Anderson J. (2002). Chronic carbon monoxide poisoning in elderly patients. Age Ageing 31(Suppl. 1):11.
51. Raub JA. (2000). The setting of health-based standards for ambient carbon monoxide and their impact on atmospheric levels. In: Penny DG, ed. Carbon Monoxide Toxicity London: CRC Press. p. 82-99.
52. Raub JA, Benignus VA. (2002). Carbon monoxide and the nervous system. Neurosci Biobehav Rev 26:925-940
53. Raw G, Coward S, Brown V, Crump D. (2004). Exposure to air pollutants in English homes. J Expo Anal Environ Epidemiol 14:585-594
54. Ryter S, Otterbein L, Morse D, Choi A. (2002). Heme oxygenase/carbon monoxide signalling pathways: regulation and functional significance. Mol Cell Biochem 234/235:249-263
55. Ryter S, Otterbein L. (2004). Carbon monoxide in biology and medicine. Bioessays 26:270-280
56. Sala C, Rescaldani M, Santin, E, Bolla G, Cuspidi C. (2009) clinical and functional correlates of platelet cyclic GMP in essential hypertensives. Am J Hypertens 22:674-679
57. Sammut I, Foresti R, Clark J, Exon D, Vesely M, Sarathchandra P, Green CJ, Motterlini R. (1998). Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 125:1437-1444
58. Siow R, Sato H, Mann G. (1999). Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 41:385-394
59. Snyder S, Jaffrey S, Zakhary R. (1998). Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res Rev 26:167-175
60. Stone J, Marletta M. (1994). Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33:5636-5640
61. Townsend C, Maynard R. (2002). Effects on health of prolonged exposure to low concentrations of carbon monoxide. Occup Environ Med 59:708-711
62. van Bel F, Latour V, Vreman H, Wong R, Stevenson D, Steendijk P, Egberts J, Krediet TG. (2005). Is carbon monoxide-mediated cyclic guanosine monophosphate production responsible for low blood pressure in neonatal respiratory distress syndrome? J Appl Physiol 98:1044-1049
63. Verma A, Hirsch D, Glatt C, Ronnett G, Snyder S. (1993). Carbon monoxide: a putative neural messenger. Science 259:381-384
64. Walker E, Hay A. (1999). Carbon monoxide poisoning. BMJ 319:1082-1083
65. Wencker M, Hauptlorenz S, Moll W, Puschendorf B. (1989). Influence of blood pressure, heart rate, age, and sex on concentrations of atrial natriuretic factor and cyclic GMP in 124 volunteers. Clin Chem 35:1519-1523
66. World Health Organisation. (2000). Air Quality Guidelines for Europe. WHO Regional publications, European series No. 91, Copenhagen: WHO Regional Office for Europe.
67. World Health Organisation. (2002). Air Quality Guidelines for Europe, 2nd edn. Copenhagen: WHO Publication.